It has been noted that off-label indication for Rituximab (RTX) in rheumatological care indubitably requires its confirmation in the randomized clinical trials. A particular cautious approach should be taken in extending the indications for therapy with gene-engineering biologicals because of the intricacy and interaction of different immunoregulatory mechanisms. Nonetheless. it is st... https://steedaes.shop/product-category/clamps/